Artemis Medicare Services reported a net profit of Rs 40.43 crore for the September 2026 quarter, a 25.9% year-on-year rise. With EBITDA margins improving to 23.8%, the company remains focused on expanding its total bed capacity to 2,000 by FY29, while navigating competitive pressures in the healthcare sector.
Artemis Medicare Services released its financial performance for the second quarter of the 2027 fiscal year on October 30, 2026. The company reported a net profit of Rs 40.43 crore, reflecting a 25.9% growth compared to the same period in the previous year. Revenue reached Rs 310 crore, highlighting sustained demand for its healthcare services and operational growth.
Operational efficiency played a key role in the quarterly performance, with the company recording an EBITDA margin of 23.8%. This marks an improvement of 141 basis points compared to the previous year. This margin expansion suggests the company is effectively managing its operational costs, including staff and medical consumables, even as it scales its infrastructure.
The company is currently pursuing a long-term capital expansion strategy. Management aims to increase total bed capacity to approximately 2,000 beds by the end of the 2029 fiscal year. This expansion is designed to capture growing demand for multi-specialty healthcare services. Successful execution of this strategy will be critical for long-term growth, as the company works to fill capacity in newer facilities.
Despite the positive financial growth, the company faces several business risks that are important for investors to monitor. These include the risk of regulatory changes, such as potential government caps on healthcare tariffs or oncology drug margins, which could impact future profitability. Additionally, the healthcare sector remains highly competitive, especially in the National Capital Region (NCR), where major players continue to vie for patient share and specialized medical talent.
Execution risk remains a significant monitorable for the business. As the company undertakes heavy capital spending for new facility construction and operational stabilization, maintaining profitability across new units will be essential. Investors may track the occupancy rates of new facilities and the company’s ability to balance rising input costs with pricing power in the coming quarters.